Literature DB >> 20303674

A 2010 update on occult hepatitis B infection.

G Raimondo1, T Pollicino, L Romanò, A R Zanetti.   

Abstract

Occult hepatitis B virus infection is a challenging issue whose virological and clinical relevance has been a source of long-lasting debate. By definition, OBI is characterized by the persistence of HBV-DNA in the liver tissue (and in some cases also in the serum) in absence of HBsAg. According to the HBV serological profile, OBI may be antibody (anti-HBc alone or together with anti-HBs) positive (seropositive OBI) or antibody negative (seronegative OBI). OBI is a complex biological entity with possible relevant clinical implications, mainly related to the intrahepatic persistence of viral cccDNA and to a strong suppression of viral replication and gene expression. Clinical observations suggest that OBI carriers may be a source of HBV transmission through blood transfusion or orthotopic liver transplantation (OLT). The state of suppression of viral replication and gene expression may be discontinued when an immunosuppressive status occurs, leading to typical hepatitis B with severe - and some times - fulminant course. The long-lasting persistence of the virus in the liver may provoke a very mild but continuing necro-inflammation that (if other causes of liver damage cohexist) may contribute over time to the progression of the chronic liver damage towards cirrhosis. In addition, OBI is supposed to be an important risk factor to HCC development since it maintains the pro-oncogenic properties typical of the overt infection. Copyright 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20303674     DOI: 10.1016/j.patbio.2010.02.003

Source DB:  PubMed          Journal:  Pathol Biol (Paris)        ISSN: 0369-8114


  44 in total

1.  Quantification of intrahepatic total HBV DNA in liver biopsies of HBV-infected patients by a modified version of COBAS® Ampliprep/COBAS®TaqMan HBV test v2.0.

Authors:  Romina Salpini; Lorenzo Piermatteo; Upkar Gill; Arianna Battisti; Francesca Stazi; Tania Guenci; Sara Giannella; Valentina Serafini; Patrick T F Kennedy; Carlo Federico Perno; Valentina Svicher; Marco Ciotti
Journal:  Med Microbiol Immunol       Date:  2017-04-11       Impact factor: 3.402

2.  Specific amino acid substitutions in the S protein prevent its excretion in vitro and may contribute to occult hepatitis B virus infection.

Authors:  Subhajit Biswas; Daniel Candotti; Jean-Pierre Allain
Journal:  J Virol       Date:  2013-05-08       Impact factor: 5.103

3.  Latent hepatitis B is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C.

Authors:  Arvind Reddy; Elizabeth May; Murray Ehrinpreis; Milton Mutchnick
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

4.  Management of chronic hepatitis B: Canadian Association for the Study of the Liver consensus guidelines.

Authors:  Carla S Coffin; Scott K Fung; Mang M Ma
Journal:  Can J Gastroenterol       Date:  2012-12       Impact factor: 3.522

5.  A pilot study of serum microRNA signatures as a novel biomarker for occult hepatitis B virus infection.

Authors:  Yuanyuan Chen; Limin Li; Zhenxian Zhou; Nan Wang; Chen-Yu Zhang; Ke Zen
Journal:  Med Microbiol Immunol       Date:  2012-03-06       Impact factor: 3.402

Review 6.  Occult hepatitis B virus infection in Egypt.

Authors:  Ashraf Elbahrawy; Alshimaa Alaboudy; Walid El Moghazy; Ahmed Elwassief; Ahmed Alashker; Abdallah Mahmoud Abdallah
Journal:  World J Hepatol       Date:  2015-06-28

Review 7.  Hepatitis B virus reactivation associated with antirheumatic therapy: Risk and prophylaxis recommendations.

Authors:  Shunsuke Mori; Shigetoshi Fujiyama
Journal:  World J Gastroenterol       Date:  2015-09-28       Impact factor: 5.742

8.  Occult hepatitis B infection in the immigrant population of Sicily, Italy.

Authors:  Fabio Tramuto; Carmelo M Maida; Giuseppina M E Colomba; Paola Di Carlo; Giovanni Mazzola; Valentina Li Vecchi; Mario Affronti; Giuseppe Montalto; Francesco Vitale
Journal:  J Immigr Minor Health       Date:  2013-08

9.  Hepatitis B virus surface antigen (HBsAg)-positive and HBsAg-negative hepatitis B virus infection among mother-teenager pairs 13 years after neonatal hepatitis B virus vaccination.

Authors:  Qing-Qing Yao; Xiao-Lian Dong; Xue-Cai Wang; Sheng-Xiang Ge; An-Qun Hu; Hai-Yan Liu; Yueping Alex Wang; Quan Yuan; Ying-Jie Zheng
Journal:  Clin Vaccine Immunol       Date:  2012-12-19

10.  Detection of hepatitis B virus DNA among accepted blood donors in Nanjing, China.

Authors:  Yong Liu; Ping Li; Cuiping Li; Jinyong Zhou; Chao Wu; Yi-Hua Zhou
Journal:  Virol J       Date:  2010-08-19       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.